Literature DB >> 22672533

Applying clinical staging to young people who present for mental health care.

Ian B Hickie1, Elizabeth M Scott, Daniel F Hermens, Sharon L Naismith, Adam J Guastella, Manreena Kaur, Anna Sidis, Bradley Whitwell, Nicholas Glozier, Tracey Davenport, Christos Pantelis, Stephen J Wood, Patrick D McGorry.   

Abstract

AIM: The study aims to apply clinical staging to young people who present for mental health care; to describe the demographic features, patterns of psychological symptoms, disability correlates and clinical stages of those young people; and to report longitudinal estimates of progression from less to more severe stages.
METHODS: The study uses cross-sectional and longitudinal assessments of young people managed in specialized youth clinics. On the basis of clinical records, subjects were assigned to a specific clinical 'stage' (i.e. 'help-seeking', 'attenuated syndrome', 'discrete disorder' or 'persistent or recurrent illness').
RESULTS: Young people (n = 209, mean age = 19.9 years (range = 12-30 years), 48% female) were selected from a broader cohort of n = 1483 subjects. Ten percent were assigned to the earliest 'help-seeking' stage, 54% to the 'attenuated syndrome' stage, 25% to the 'discrete disorder' stage and 11% to the later 'persistent or recurrent illness' stage. The interrater reliability of independent ratings at baseline was acceptable (κ = 0.71). Subjects assigned to the 'attenuated syndrome' stage reported symptom and disability scores that were similar to those assigned to later stages. Longitudinally (median = 48 weeks), transition to later clinical stages were 11% of the 'help-seeking', 19% of the 'attenuated syndrome' and 33% of the 'discrete disorder' groups.
CONCLUSION: Among young people presenting for mental health care, most are clinically staged as having 'attenuated syndromes'. Despite access to specialized treatment, a significant number progress to more severe or persistent disorders.
© 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22672533     DOI: 10.1111/j.1751-7893.2012.00366.x

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  56 in total

1.  Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.

Authors:  Jadon R Webb; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert K Heinssen; Larry J Seidman; Sarah I Tarbox; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Scott W Woods
Journal:  Schizophr Bull       Date:  2015-09       Impact factor: 9.306

2.  Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic Disorders.

Authors:  Frank Iorfino; Elizabeth M Scott; Joanne S Carpenter; Shane P Cross; Daniel F Hermens; Madhura Killedar; Alissa Nichles; Natalia Zmicerevska; Django White; Adam J Guastella; Jan Scott; Patrick D McGorry; Ian B Hickie
Journal:  JAMA Psychiatry       Date:  2019-11-01       Impact factor: 21.596

3.  Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder.

Authors:  Michael R Jarcho; George M Slavich; Hana Tylova-Stein; Owen M Wolkowitz; Heather M Burke
Journal:  Biol Psychol       Date:  2013-02-11       Impact factor: 3.251

Review 4.  The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic review.

Authors:  Frank Iorfino; Ian B Hickie; Rico S C Lee; Jim Lagopoulos; Daniel F Hermens
Journal:  BMC Psychiatry       Date:  2016-05-23       Impact factor: 3.630

5.  Comorbidity of physical and mental disorders in the neurodevelopmental genomics cohort study.

Authors:  Kathleen R Merikangas; Monica E Calkins; Marcy Burstein; Jian-Ping He; Rosetta Chiavacci; Tarannum Lateef; Kosha Ruparel; Ruben C Gur; Thomas Lehner; Hakon Hakonarson; Raquel E Gur
Journal:  Pediatrics       Date:  2015-03-09       Impact factor: 7.124

6.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

7.  The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

Authors:  Glenda M. MacQueen; Stefanie Hassel; Stephen R. Arnott; Addington Jean; Christopher R. Bowie; Signe L. Bray; Andrew D. Davis; Jonathan Downar; Jane A. Foster; Benicio N. Frey; Benjamin I. Goldstein; Geoffrey B. Hall; Kate L. Harkness; Jacqueline Harris; Raymond W. Lam; Catherine Lebel; Roumen Milev; Daniel J. Müller; Sagar V. Parikh; Sakina Rizvi; Susan Rotzinger; Gulshan B. Sharma; Claudio N. Soares; Gustavo Turecki; Fidel Vila-Rodriguez; Joanna Yu; Mojdeh Zamyadi; Stephen C. Strother; Sidney H. Kennedy
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

8.  An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial.

Authors:  Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

9.  Treatment History of Youth At-Risk for Serious Mental Illness.

Authors:  Megan S Farris; Glenda MacQueen; Benjamin I Goldstein; JianLi Wang; Sidney H Kennedy; Signe Bray; Catherine Lebel; Jean Addington
Journal:  Can J Psychiatry       Date:  2018-08-02       Impact factor: 4.356

10.  Baby or bathwater? Referrals of "non-cases" in a targeted early identification intervention for psychosis.

Authors:  Gerald Jordan; Miriam Kinkaid; Srividya N Iyer; Ridha Joober; Karen Goldberg; Ashok Malla; Jai L Shah
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-03-14       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.